Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$40.85 - $77.67 $881,420 - $1.68 Million
-21,577 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$59.95 - $92.06 $56,113 - $86,168
-936 Reduced 4.16%
21,577 $1.56 Million
Q4 2021

Feb 03, 2022

SELL
$81.07 - $121.29 $17,024 - $25,470
-210 Reduced 0.92%
22,513 $1.83 Million
Q3 2021

Nov 10, 2021

SELL
$101.99 - $166.36 $625,198 - $1.02 Million
-6,130 Reduced 21.25%
22,723 $2.65 Million
Q2 2021

Aug 06, 2021

SELL
$141.6 - $179.06 $176,008 - $222,571
-1,243 Reduced 4.13%
28,853 $4.78 Million
Q1 2021

May 13, 2021

BUY
$132.81 - $182.18 $1.53 Million - $2.1 Million
11,517 Added 61.99%
30,096 $4.2 Million
Q4 2020

Feb 12, 2021

SELL
$138.17 - $184.34 $53,609 - $71,523
-388 Reduced 2.05%
18,579 $3.22 Million
Q3 2020

Nov 13, 2020

SELL
$114.09 - $145.51 $370,222 - $472,179
-3,245 Reduced 14.61%
18,967 $2.64 Million
Q2 2020

Aug 06, 2020

SELL
$89.45 - $129.85 $134,622 - $195,424
-1,505 Reduced 6.35%
22,212 $2.65 Million
Q1 2020

May 11, 2020

BUY
$70.23 - $144.31 $1.67 Million - $3.42 Million
23,717 New
23,717 $2.37 Million
Q4 2018

Feb 12, 2019

SELL
$35.43 - $56.29 $2.16 Million - $3.43 Million
-60,876 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$44.22 - $75.47 $751,165 - $1.28 Million
-16,987 Reduced 21.82%
60,876 $3.47 Million
Q2 2018

Aug 09, 2018

BUY
$72.38 - $92.5 $1.65 Million - $2.11 Million
22,810 Added 41.43%
77,863 $6.22 Million
Q4 2017

Jan 31, 2018

BUY
$65.94 - $93.31 $496,594 - $702,717
7,531 Added 15.85%
55,053 $3.8 Million
Q3 2017

Oct 18, 2017

BUY
$80.87 - $91.08 $3.84 Million - $4.33 Million
47,522
47,522 $4.32 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $147M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.